After FDA Submission, Danish Firm BioPorto Aims For 2023 Launch of Kidney Injury Test 360Dx, 23 Nov 2022 NEW YORK – After a bumpy road to commercialization, Danish diagnostic firm BioPorto has submitted its test for acute kidney…